Neuromodulation Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the neuromodulation market looks promising with opportunities in applications, such as spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation, and respiratory electrical stimulation. The global neuromodulation market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing research and development activities in neurology and growing prevalence of neurological disorders.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global neuromodulation market report, please download the report brochure.
In this market, internal neuromodulation is the largest technology of neuromodulation, whereas wastewater is the largest application. Growth in various segments of the neuromodulation market are given below:
The study includes trends and forecast for the global neuromodulation market by technology, biomaterial, application, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that internal neuromodulators will remain the largest product segment over the forecast period due to rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness of neurodegenerative disorders.
Within this market, deep brain stimulation will remain the largest application segment over the forecast period due to the rising incidence of generic diseases and growing R&D activity for neuromodulation applications.
North America will remain the largest region over the forecast period due to rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer’s and Parkinson’s diseases, and the increase in awareness of the safety and efficacy of neurostimulator devices in the region.
Features of the Global Neuromodulation Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global neuromodulation market by technology (internal neuromodulation (spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electrical stimulation) and external neuromodulation (transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES))), biomaterial (metallic biomaterials, polymeric biomaterials, and ceramic biomaterials), application (spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation, and respiratory electrical stimulation), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global neuromodulation market?
Q.5 What are the business risks and threats to the global neuromodulation market?
Q.6 What are the emerging trends in this neuromodulation market and the reasons behind them?
Q.7 What are some changing demands of customers in this neuromodulation market?
Q.8 What are the new developments in this neuromodulation market? Which companies are leading these developments?
Q.9 Who are the major players in this neuromodulation market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this neuromodulation market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global neuromodulation market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Technology (Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), and Respiratory Electrical Stimulation (RES))), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials), and Application (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Stimulation)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the neuromodulation market looks promising with opportunities in applications, such as spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation, and respiratory electrical stimulation. The global neuromodulation market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing research and development activities in neurology and growing prevalence of neurological disorders.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global neuromodulation market report, please download the report brochure.
In this market, internal neuromodulation is the largest technology of neuromodulation, whereas wastewater is the largest application. Growth in various segments of the neuromodulation market are given below:
The study includes trends and forecast for the global neuromodulation market by technology, biomaterial, application, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Internal Neuromodulation
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- External Neuromodulation
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Transcranial Magnetic Stimulation (TMS)
- Respiratory Electrical Stimulation (RES)
- Metallic Biomaterials
- Polymeric Biomaterials
- Ceramic Biomaterials
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Gastric Electrical Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- German
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that internal neuromodulators will remain the largest product segment over the forecast period due to rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness of neurodegenerative disorders.
Within this market, deep brain stimulation will remain the largest application segment over the forecast period due to the rising incidence of generic diseases and growing R&D activity for neuromodulation applications.
North America will remain the largest region over the forecast period due to rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer’s and Parkinson’s diseases, and the increase in awareness of the safety and efficacy of neurostimulator devices in the region.
Features of the Global Neuromodulation Market
- Market Size Estimates: Global neuromodulation market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global neuromodulation market size by various segments, such as technology, biomaterial, and application in terms of value.
- Regional Analysis: Global neuromodulation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different technology, biomaterial, application, and region for the global neuromodulation market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global neuromodulation market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global neuromodulation market by technology (internal neuromodulation (spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electrical stimulation) and external neuromodulation (transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES))), biomaterial (metallic biomaterials, polymeric biomaterials, and ceramic biomaterials), application (spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation, and respiratory electrical stimulation), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global neuromodulation market?
Q.5 What are the business risks and threats to the global neuromodulation market?
Q.6 What are the emerging trends in this neuromodulation market and the reasons behind them?
Q.7 What are some changing demands of customers in this neuromodulation market?
Q.8 What are the new developments in this neuromodulation market? Which companies are leading these developments?
Q.9 Who are the major players in this neuromodulation market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this neuromodulation market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global neuromodulation market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Technology (Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), and Respiratory Electrical Stimulation (RES))), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials), and Application (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Stimulation)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Neuromodulation Market Trends and Forecast
3.3: Global Neuromodulation Market by Technology
3.3.1: Internal Neuromodulation
3.3.1.1: Spinal Cord Stimulation
3.3.1.2: Deep Brain Stimulation
3.3.1.3: Vagus Nerve Stimulation
3.3.1.4: Sacral Nerve Stimulation
3.3.1.5: Gastric Electrical Stimulation
3.3.2: Hybridization-based Approach
3.3.2.1: Transcutaneous Electrical Nerve Stimulation (TENS)
3.3.2.2: Transcranial Magnetic Stimulation (TMS)
3.3.2.3: Respiratory Electrical Stimulation (RES)
3.4: Global Neuromodulation Market by Biomaterial
3.4.1: Metallic Biomaterials
3.4.2: Polymeric Biomaterials
3.4.3: Ceramic Biomaterials
3.5: Global Neuromodulation Market by Application
3.5.1: Spinal Cord Stimulation
3.5.2: Deep Brain Stimulation
3.5.3: Sacral Nerve Stimulation
3.5.4: Vagus Nerve Stimulation
3.5.5: Gastric Electrical Stimulation
3.5.6: Transcutaneous Electrical Nerve Stimulation
3.5.7: Transcranial Magnetic Stimulation
3.5.8: Respiratory Electrical Stimulation
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Neuromodulation Market by Region
4.2: North American Neuromodulation Market
4.2.1: Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.2.2: Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.2.3: Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.2.4: The United States Neuromodulation Market
4.2.5: The Canadian Neuromodulation Market
4.2.6: The Mexican Neuromodulation Market
4.3: European Neuromodulation Market
4.3.1: Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.3.2: Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.3.3: Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.3.4: The United Kingdom Neuromodulation Market
4.3.5: The Spanish Neuromodulation Market
4.3.6: The German Neuromodulation Market
4.3.7: The French Neuromodulation Market
4.4: APAC Neuromodulation Market
4.4.1: Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.4.2: Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.4.3: Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.4.4: The Chinese Neuromodulation Market
4.4.5: The Indian Neuromodulation Market
4.4.6: The Japanese Neuromodulation Market
4.5: ROW Neuromodulation Market
4.5.1: Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.5.2: Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.5.3: Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.5.4: Brazilian Neuromodulation Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Neuromodulation Market by Technology
7.1.2: Growth Opportunities for the Global Neuromodulation Market by Biomaterial
7.1.3: Growth Opportunities for the Global Neuromodulation Market by Application
7.1.4: Growth Opportunities for the Global Neuromodulation Market by Region
7.2: Emerging Trends in the Global Neuromodulation Market
7.3: Strategic Analysis
7.3.1:New Product Development
7.3.2: Capacity Expansion of the Global Neuromodulation Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neuromodulation Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific
8.2: Illumina, Inc.
8.3: BGI
8.4: Agilent Technologies
8.5: Eurofins Scientific
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Neuromodulation Market Trends and Forecast
3.3: Global Neuromodulation Market by Technology
3.3.1: Internal Neuromodulation
3.3.1.1: Spinal Cord Stimulation
3.3.1.2: Deep Brain Stimulation
3.3.1.3: Vagus Nerve Stimulation
3.3.1.4: Sacral Nerve Stimulation
3.3.1.5: Gastric Electrical Stimulation
3.3.2: Hybridization-based Approach
3.3.2.1: Transcutaneous Electrical Nerve Stimulation (TENS)
3.3.2.2: Transcranial Magnetic Stimulation (TMS)
3.3.2.3: Respiratory Electrical Stimulation (RES)
3.4: Global Neuromodulation Market by Biomaterial
3.4.1: Metallic Biomaterials
3.4.2: Polymeric Biomaterials
3.4.3: Ceramic Biomaterials
3.5: Global Neuromodulation Market by Application
3.5.1: Spinal Cord Stimulation
3.5.2: Deep Brain Stimulation
3.5.3: Sacral Nerve Stimulation
3.5.4: Vagus Nerve Stimulation
3.5.5: Gastric Electrical Stimulation
3.5.6: Transcutaneous Electrical Nerve Stimulation
3.5.7: Transcranial Magnetic Stimulation
3.5.8: Respiratory Electrical Stimulation
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Neuromodulation Market by Region
4.2: North American Neuromodulation Market
4.2.1: Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.2.2: Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.2.3: Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.2.4: The United States Neuromodulation Market
4.2.5: The Canadian Neuromodulation Market
4.2.6: The Mexican Neuromodulation Market
4.3: European Neuromodulation Market
4.3.1: Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.3.2: Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.3.3: Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.3.4: The United Kingdom Neuromodulation Market
4.3.5: The Spanish Neuromodulation Market
4.3.6: The German Neuromodulation Market
4.3.7: The French Neuromodulation Market
4.4: APAC Neuromodulation Market
4.4.1: Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.4.2: Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.4.3: Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.4.4: The Chinese Neuromodulation Market
4.4.5: The Indian Neuromodulation Market
4.4.6: The Japanese Neuromodulation Market
4.5: ROW Neuromodulation Market
4.5.1: Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.5.2: Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.5.3: Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.5.4: Brazilian Neuromodulation Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Neuromodulation Market by Technology
7.1.2: Growth Opportunities for the Global Neuromodulation Market by Biomaterial
7.1.3: Growth Opportunities for the Global Neuromodulation Market by Application
7.1.4: Growth Opportunities for the Global Neuromodulation Market by Region
7.2: Emerging Trends in the Global Neuromodulation Market
7.3: Strategic Analysis
7.3.1:New Product Development
7.3.2: Capacity Expansion of the Global Neuromodulation Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neuromodulation Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific
8.2: Illumina, Inc.
8.3: BGI
8.4: Agilent Technologies
8.5: Eurofins Scientific
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
